The Effect of Resveratrol on Ischemia–Reperfusion Induced Oxidative Rat Ovary Injury: A Biochemical, Histopathological, and Genetic Evaluation
Özet
Objective: The cellular protective effects of resveratrol and co-enzyme Q10 supplementation have been reported in different models. However, there is insufficient data on the effects of resveratrol supplementation on oxidative DNA damage and co-enzyme Q10 levels in ovarian ischemia–reperfusion injury. The current study aims to investigate how resveratrol supplementation affects oxidative DNA damage, co-enzyme Q10 levels, inflammatory and proinflammatory indicators, and growth factors in ovarian ischemia– reperfusion injury. Methods: Thirty albino Wistar female rats were divided into 5 groups; control, ovarian ischemia–reperfusion, and ischemia–reperfusion + treatment (25, 50, and 100 mg/kg resveratrol). Hematoxylin–eosin stain was used to evaluate histopathological results. The levels of 8-oxo-2ʹ-deoxy guanosine and co-enzyme Q10 were obtained by enzyme-linked immunosorbent assay. Following RNA isolation, the expression of tumor necrosis factor-α , interleukin-1β, transforming growth factor-β3, hepatocyte growth factor, epidermal growth factor, and vascular endothelial growth factor was assessed. Results: Regarding the histopathological evaluation score, 8-oxo -2ʹ-d eoxyg uanos ine levels, and co-enzyme Q10 levels, there was no statistically significant difference between the ischemia–reperfusion group and the groups that received resveratrol treatment. Tumor necrosis factor-α, interleukin-1β, transforming growth factor-β3, hepatocyte growth factor, epidermal growth factor, and vascular endothelial growth factor expression levels were significantly decreased in the resveratrol -treated groups compared to the ischemia–reperfusion group. Conclusion: The results imply that the positive effects of resveratrol on infla mmato ry-pr oinfl ammat ory cytokine expression may be a major contributor to the anti-oxidant, anti-inflammatory, anti-proliferative, anti-carcinogenic, and therapeutic effects of resveratrol documented in the literature.
Anahtar Kelimeler
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | SAYAR, ILYAS | |
| dc.contributor.author | Bakan, Nuri | |
| dc.contributor.author | GÜRBÜZEL, MEHMET | |
| dc.contributor.author | Akbaş, Nergis | |
| dc.date.accessioned | 2026-10-18T20:56:22.599388485Z | |
| dc.date.available | 2026-10-18T20:56:22.599388485Z | |
| dc.date.issued | 2023 | |
| dc.description.abstract | Objective: The cellular protective effects of resveratrol and co-enzyme Q10 supplementation have been reported in different models. However, there is insufficient data on the effects of resveratrol supplementation on oxidative DNA damage and co-enzyme Q10 levels in ovarian ischemia–reperfusion injury. The current study aims to investigate how resveratrol supplementation affects oxidative DNA damage, co-enzyme Q10 levels, inflammatory and proinflammatory indicators, and growth factors in ovarian ischemia– reperfusion injury. Methods: Thirty albino Wistar female rats were divided into 5 groups; control, ovarian ischemia–reperfusion, and ischemia–reperfusion + treatment (25, 50, and 100 mg/kg resveratrol). Hematoxylin–eosin stain was used to evaluate histopathological results. The levels of 8-oxo-2ʹ-deoxy guanosine and co-enzyme Q10 were obtained by enzyme-linked immunosorbent assay. Following RNA isolation, the expression of tumor necrosis factor-α , interleukin-1β, transforming growth factor-β3, hepatocyte growth factor, epidermal growth factor, and vascular endothelial growth factor was assessed. Results: Regarding the histopathological evaluation score, 8-oxo -2ʹ-d eoxyg uanos ine levels, and co-enzyme Q10 levels, there was no statistically significant difference between the ischemia–reperfusion group and the groups that received resveratrol treatment. Tumor necrosis factor-α, interleukin-1β, transforming growth factor-β3, hepatocyte growth factor, epidermal growth factor, and vascular endothelial growth factor expression levels were significantly decreased in the resveratrol -treated groups compared to the ischemia–reperfusion group. Conclusion: The results imply that the positive effects of resveratrol on infla mmato ry-pr oinfl ammat ory cytokine expression may be a major contributor to the anti-oxidant, anti-inflammatory, anti-proliferative, anti-carcinogenic, and therapeutic effects of resveratrol documented in the literature. | |
| dc.identifier.doi | 10.5152/abcr.2023.22046 | |
| dc.identifier.eissn | 2687-4482 | |
| dc.identifier.endpage | 239 | |
| dc.identifier.issn | 2687-4520 | |
| dc.identifier.issue | 2 | |
| dc.identifier.startpage | 230 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/ebyu/18107 | |
| dc.identifier.volume | 5 | |
| dc.language.iso | en | |
| dc.relation.ispartof | Archives of Basic and Clinical Research | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Tıbbi Araştırmalar Deneysel | |
| dc.subject | Onkoloji | |
| dc.subject | İmmünoloji | |
| dc.subject | Kalp ve Kalp Damar Sistemi | |
| dc.title | The Effect of Resveratrol on Ischemia–Reperfusion Induced Oxidative Rat Ovary Injury: A Biochemical, Histopathological, and Genetic Evaluation | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| rdl.citation.trdizin | 0 | |
| rdl.department | ERZİNCAN BİNALİ YILDIRIM ÜNİVERSİTESİ | |
| rdl.department | ATATÜRK ÜNİVERSİTESİ | |
| rdl.source.index | TRDIZIN |
